Showing results (51-60 of 492) with videos related to
Sort By:
Pageof 50
Seminars in Hematology|April 5, 2026
Targeted immunoPET imaging of multiple myelomaGary A Ulaner, Ola LandgrenClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple MyelomaOla Landgren, S Vincent RajkumarBritish Journal of Haematology|February 7, 2020
Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myelomaMarion Eveillard, Even Rustad, Mikhail Roshal, et al.Cytometry. Part B, Clinical Cytometry|September 15, 2010
Prevalence, clinical aspects, and natural history of IgM MGUSMary L McMaster, Ola LandgrenHematology/Oncology Clinics of North America|October 3, 2007
New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphomaOla Landgren, Neil E CaporasoBritish Journal of Haematology|November 21, 2007
Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseasesOla Landgren, Robert A KyleClinical Lymphoma, Myeloma & Leukemia|April 2, 2011
What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?Sigurdur Y Kristinsson, Ola LandgrenClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2013
Biologic frontiers in multiple myeloma: from biomarker identification to clinical practiceOla Landgren, Gareth J MorganSeminars in Hematology|January 15, 2011
Development of early treatment strategies for high-risk myeloma precursor disease in the futureOla Landgren, S Vincent RajkumarPageof 50